Telix Pharmaceuticals (Australia) Analysis
| TLX Stock | 25.74 0.80 3.21% |
Telix Pharmaceuticals is undervalued with Real Value of 28.67 and Hype Value of 25.59. The main objective of Telix Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Telix Pharmaceuticals is worth, separate from its market price. There are two main types of Telix Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Telix Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Telix Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Telix Pharmaceuticals stock is traded in Australia on Australian Securities Exchange, with the market opening at 09:50:00 and closing at 16:12:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Australia. Telix Pharmaceuticals is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Australia Day, Australia Day ( substitute day ), Good Friday, Easter Monday, ANZAC Day. Telix Stock trading window is adjusted to Australia/Sydney timezone.
Telix |
Telix Stock Analysis Notes
About 41.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. To find out more about Telix Pharmaceuticals contact the company at 61 3 9093 3855 or learn more at https://telixpharma.com.Telix Pharmaceuticals Quarterly Total Revenue |
|
Telix Pharmaceuticals Investment Alerts
| Telix Pharmaceuticals is unlikely to experience financial distress in the next 2 years | |
| About 41.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Telix Pharmaceuticals Updates Securities Policy Amid Market Interest - TipRanks |
Telix Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.4 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Telix Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Telix Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Telix Profitablity
Telix Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Telix Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Telix Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Telix Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Telix Pharmaceuticals' profitability requires more research than a typical breakdown of Telix Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09. Management Efficiency
Telix Pharmaceuticals has return on total asset (ROA) of 0.0797 % which means that it generated a profit of $0.0797 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2049 %, meaning that it generated $0.2049 on every $100 dollars invested by stockholders. Telix Pharmaceuticals' management efficiency ratios could be used to measure how well Telix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Telix Pharmaceuticals' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 418.2 M in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 48.8 M in 2024.Leadership effectiveness at Telix Pharmaceuticals is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin 0.0949 | Profit Margin 0.0762 | Beta 2.384 | Return On Assets 0.0797 | Return On Equity 0.2049 |
Technical Drivers
As of the 19th of December, Telix Pharmaceuticals has the Coefficient Of Variation of 377.16, semi deviation of 1.48, and Risk Adjusted Performance of 0.2171. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telix Pharmaceuticals, as well as the relationship between them.Telix Pharmaceuticals Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Telix Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Telix Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Telix Pharmaceuticals Outstanding Bonds
Telix Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Telix Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Telix bonds can be classified according to their maturity, which is the date when Telix Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Telix Pharmaceuticals Predictive Daily Indicators
Telix Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Telix Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 72561.61 | |||
| Daily Balance Of Power | 0.6957 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 25.23 | |||
| Day Typical Price | 25.4 | |||
| Price Action Indicator | 0.91 | |||
| Period Momentum Indicator | 0.8 |
Telix Pharmaceuticals Forecast Models
Telix Pharmaceuticals' time-series forecasting models are one of many Telix Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telix Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Telix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Telix Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Telix Pharmaceuticals. By using and applying Telix Stock analysis, traders can create a robust methodology for identifying Telix entry and exit points for their positions.
Telix Pharmaceuticals is entity of Australia. It is traded as Stock on AU exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Telix Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.